Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Aspirin in CHD with GI Disease
NCT04805710Phase 4Unknown
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Mar 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rivaroxaban in coronary heart disease (CHD), sponsored by General Hospital of the Northern Theater Command. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT04805710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04805710.